Safety and Immunogenicity of Ad4-HIV Envelope Vaccine Vectors in Healthy Volunteers

计划入组 300 人 · 首次发布于 2019 年 3 月 18 日

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines

计划入组 56 人 · 首次发布于 2001 年 8 月 31 日

A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals

计划入组 56 人 · 首次发布于 2001 年 8 月 31 日

N332-GT5 gp140

VRC-HIVADV014-00-VP

Ad-4 vectored vaccine(PaxVax)

Worcester HIV Vaccine

United States

HIV VACCINE TRIALS NETWORK

United States

THE HIV NETHERLANDS AUSTRALIA THAILAND RESEARCH COLLABORATION

Thailand

Accelerated Manufacturing Platform Enables Rapid HIV Vaccine Production for Clinical Trials

First-in-Human HIV Vaccine Induces Virus-Specific Neutralizing Antibodies

Single-Dose HIV Vaccine Candidate Induces Neutralizing Antibodies in Nonhuman Primates